Overview

Optimal Dose of Alfentanil for Removal of Supreme Laryngeal Mask Airway During Emergence From Desflurane Anaesthesia

Status:
Completed

Trial end date:
2011-11-01

Target enrollment:
0

Participant gender:
All

Summary

This study aims to determine the optimal dose of alfentanil in suppressing the airway reflexes during supreme LMA removal in anaesthetized adult.

Phase:

N/A

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

University of Malaya

Collaborator:

Malaysian Society of Anaesthesiologists

Treatments:

Alfentanil
Desflurane

Criteria

Inclusion Criteria:

1. ASA I and II patients

2. Age 18 to 49 years old

3. Minor elective day care surgery (> 20 minute and less than 2 hours) which require
local anaesthetic infiltration and does not require use of long acting opioids.

Exclusion Criteria:

1. Potential difficult airway

2. Reactive airway disease or sign and symptoms of upper respiratory tract infection.

3. History of cardiac, pulmonary and renal diseases

4. Body Mass Index > 30 kgm2.

5. Risk of aspiration.

6. Poor dentition with high risk of damage.

7. Patient refusal.